학술논문

Phase 1 multicenter dose escalation and dose expansion study of antibody-drug conjugate (ADC) MYTX-011 in subjects with non-small cell lung cancer.
Document Type
Article
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pTPS9147-TPS9147, 1p
Subject
Language
ISSN
0732183X